Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib in Advanced or Relapsed MALT Lymphoma
NCT00373906Phase 2Completed
- Sponsor
- Medical University of Vienna
- Modality
- Small Molecules, Modified Peptides
01
Overview
A Phase 2 trial of bortezomib in extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, sponsored by Medical University of Vienna. Status: completed.
02
Drugs
bortezomib
03
Conditions
extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
Beyond the preview
Go deeper on NCT00373906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373906.